180 related articles for article (PubMed ID: 36366510)
1. Effects of Achieving SVR on Clinical Characteristics and Surgical Outcomes in Patients Who Developed Early-Stage HCV-Related Hepatocellular Carcinoma and Received Curative Resection: Preoperative versus Postoperative SVR.
Hsu PY; Liang PC; Huang CI; Hsieh MH; Tsai YS; Lin TC; Yeh ML; Huang CF; Wang CW; Jang TY; Lin YH; Lin ZY; Chuang WL; Dai CY
Viruses; 2022 Oct; 14(11):. PubMed ID: 36366510
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon.
Petta S; Cabibbo G; Barbara M; Attardo S; Bucci L; Farinati F; Giannini EG; Tovoli F; Ciccarese F; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Borzio F; Sacco R; Virdone R; Marra F; Felder M; Morisco F; Benvegnù L; Gasbarrini A; Svegliati-Baroni G; Foschi FG; Olivani A; Masotto A; Nardone G; Colecchia A; Persico M; Boccaccio V; Craxì A; Bruno S; Trevisani F; Cammà C;
Aliment Pharmacol Ther; 2017 Jan; 45(1):160-168. PubMed ID: 27790734
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics and prognosis of HCC occurrence after antiviral therapy for HCV patients between sustained and non-sustained responders.
Sou FM; Wu CK; Chang KC; Lu SN; Wang JH; Hung CH; Chen CH; Kee KM; Yen YH; Lin MT; Tsai MC; Hu TH
J Formos Med Assoc; 2019 Jan; 118(1 Pt 3):504-513. PubMed ID: 30527565
[TBL] [Abstract][Full Text] [Related]
4. Association between sustained virological response and clinical outcomes in patients with hepatitis C infection and hepatocellular carcinoma.
Parikh ND; Mehta N; Hoteit MA; Yang JD; John BV; Moon AM; Salgia RJ; Pillai A; Kassab I; Saeed N; Thyssen E; Nathani P; McKinney J; Chan W; Durkin C; Connor M; Alsudaney M; Konjeti R; Durand B; Nissen NN; Kim HP; Paknikar R; Rich NE; Schipper MJ; Singal AG
Cancer; 2022 Oct; 128(19):3470-3478. PubMed ID: 35796530
[TBL] [Abstract][Full Text] [Related]
5. HCV Eradication in Primary or Secondary Prevention Optimizes Hepatocellular Carcinoma Curative Management.
Nahon P; Layese R; Cagnot C; Asselah T; Guyader D; Pol S; Pageaux GP; De Lédinghen V; Ouzan D; Zoulim F; Audureau E;
Cancer Prev Res (Phila); 2021 May; 14(5):581-592. PubMed ID: 33608313
[TBL] [Abstract][Full Text] [Related]
6. Effect of achieving sustained virological response before hepatitis C virus-related hepatocellular carcinoma occurrence on survival and recurrence after curative surgical microwave ablation.
Ryu T; Takami Y; Wada Y; Tateishi M; Matsushima H; Yoshitomi M; Mikagi K; Saitsu H
Hepatol Int; 2018 Mar; 12(2):149-157. PubMed ID: 29488056
[TBL] [Abstract][Full Text] [Related]
7. Systematic review with meta-analysis: effectiveness of direct-acting antiviral treatment for hepatitis C in patients with hepatocellular carcinoma.
He S; Lockart I; Alavi M; Danta M; Hajarizadeh B; Dore GJ
Aliment Pharmacol Ther; 2020 Jan; 51(1):34-52. PubMed ID: 31808566
[TBL] [Abstract][Full Text] [Related]
8. Improved survival of patients with hepatocellular carcinoma and compensated hepatitis C virus-related cirrhosis who attained sustained virological response.
Bruno S; Di Marco V; Iavarone M; Roffi L; Boccaccio V; Crosignani A; Cabibbo G; Rossi S; Calvaruso V; Aghemo A; Giacomelli L; Craxì A; Colombo M; Maisonneuve P
Liver Int; 2017 Oct; 37(10):1526-1534. PubMed ID: 28418617
[TBL] [Abstract][Full Text] [Related]
9. Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients With Baseline Cirrhosis or High FIB-4 Scores.
Ioannou GN; Beste LA; Green PK; Singal AG; Tapper EB; Waljee AK; Sterling RK; Feld JJ; Kaplan DE; Taddei TH; Berry K
Gastroenterology; 2019 Nov; 157(5):1264-1278.e4. PubMed ID: 31356807
[TBL] [Abstract][Full Text] [Related]
10. Regional Differences in Clinical Presentation and Prognosis of Patients With Post-Sustained Virologic Response Hepatocellular Carcinoma.
Toyoda H; Kanneganti M; Melendez-Torres J; Parikh ND; Jalal PK; Piñero F; Mendizabal M; Ridruejo E; Cheinquer H; Casadei-Gardini A; Weinmann A; Peck-Radosavljevic M; Dufour JF; Radu P; Shiha G; Soliman R; Sarin SK; Kumar M; Wang JH; Tangkijvanich P; Sukeepaisarnjaroen W; Atsukawa M; Uojima H; Nozaki A; Nakamuta M; Takaguchi K; Hiraoka A; Abe H; Matsuura K; Watanabe T; Shimada N; Tsuji K; Ishikawa T; Mikami S; Itobayashi E; Singal AG; Johnson PJ
Clin Gastroenterol Hepatol; 2024 Jan; 22(1):72-80.e4. PubMed ID: 37442316
[TBL] [Abstract][Full Text] [Related]
11. The influence of direct-acting antivirals in hepatitis C virus related hepatocellular carcinoma after curative treatment.
Kuo YH; Wang JH; Chang KC; Hung CH; Lu SN; Hu TH; Yen YH; Kee KM; Chen CH
Invest New Drugs; 2020 Feb; 38(1):202-210. PubMed ID: 31701431
[TBL] [Abstract][Full Text] [Related]
12. The Achievement of a Sustained Virological Response Either Before or After Hepatectomy Improves the Prognosis of Patients with Primary Hepatitis C Virus-Related Hepatocellular Carcinoma.
Okamura Y; Sugiura T; Ito T; Yamamoto Y; Ashida R; Ohgi K; Uesaka K
Ann Surg Oncol; 2019 Dec; 26(13):4566-4575. PubMed ID: 31602577
[TBL] [Abstract][Full Text] [Related]
13. The association between hepatocellular carcinoma and direct-acting anti-viral treatment in patients with decompensated cirrhosis.
Mecci AJ; Kemos P; Leen C; Lawson A; Richardson P; Khakoo SI; Agarwal K; Mutimer D; Rosenberg WM; Foster GR; Irving WL;
Aliment Pharmacol Ther; 2019 Jul; 50(2):204-214. PubMed ID: 31149748
[TBL] [Abstract][Full Text] [Related]
14. Impact of Sustained Virological Response to Interferon Therapy on Recurrence of Hepatitis C Virus-Related Hepatocellular Carcinoma.
Shinkawa H; Hasegawa K; Arita J; Akamatsu N; Kaneko J; Sakamoto Y; Kokudo N
Ann Surg Oncol; 2017 Oct; 24(11):3196-3202. PubMed ID: 28707053
[TBL] [Abstract][Full Text] [Related]
15. Long-term effect of sustained virological response on hepatocellular carcinoma in patients with hepatitis C in Canada.
Janjua NZ; Chong M; Kuo M; Woods R; Wong J; Yoshida EM; Sherman M; Butt ZA; Samji H; Cook D; Yu A; Alvarez M; Tyndall M; Krajden M
J Hepatol; 2017 Mar; 66(3):504-513. PubMed ID: 27818234
[TBL] [Abstract][Full Text] [Related]
16. Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients.
Cabibbo G; Celsa C; Calvaruso V; Petta S; Cacciola I; Cannavò MR; Madonia S; Rossi M; Magro B; Rini F; Distefano M; Larocca L; Prestileo T; Malizia G; Bertino G; Benanti F; Licata A; Scalisi I; Mazzola G; Di Rosolini MA; Alaimo G; Averna A; Cartabellotta F; Alessi N; Guastella S; Russello M; Scifo G; Squadrito G; Raimondo G; Trevisani F; Craxì A; Di Marco V; Cammà C;
J Hepatol; 2019 Aug; 71(2):265-273. PubMed ID: 30959157
[TBL] [Abstract][Full Text] [Related]
17. The Impact of Direct-Acting Antiviral Therapy on the Risk of Recurrence after Curative Resection in Patients with Hepatitis-C-Virus-Related Early Stage Hepatocellular Carcinoma.
Chen YS; Huang KH; Wang PM; Chuang CH; Yong CC; Liu YW; Huang PY; Yao CC; Lin YP; Tsai MC
Medicina (Kaunas); 2022 Feb; 58(2):. PubMed ID: 35208582
[No Abstract] [Full Text] [Related]
18. Effect of previous interferon-based therapy on recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinoma.
Saito T; Chiba T; Suzuki E; Shinozaki M; Goto N; Kanogawa N; Motoyama T; Ogasawara S; Ooka Y; Tawada A; Kanda T; Miyazaki M; Yokosuka O
Int J Med Sci; 2014; 11(7):707-12. PubMed ID: 24843320
[TBL] [Abstract][Full Text] [Related]
19. Does interferon-free direct-acting antiviral therapy for hepatitis C after curative treatment for hepatocellular carcinoma lead to unexpected recurrences of HCC? A multicenter study by the Japanese Red Cross Hospital Liver Study Group.
Mashiba T; Joko K; Kurosaki M; Ochi H; Osaki Y; Kojima Y; Nakata R; Goto T; Takehiro A; Kimura H; Mitsuda A; Kawanami C; Uchida Y; Ogawa C; Kusakabe A; Narita R; Ide Y; Abe T; Tsuji K; Kitamura T; Okada K; Sohda T; Shigeno M; Satou T; Izumi N
PLoS One; 2018; 13(4):e0194704. PubMed ID: 29659591
[TBL] [Abstract][Full Text] [Related]
20. Timely eradication of HCV viremia by PegIFN/RBV is crucial in prevention of post RFA recurrence in CHC-HCC patients.
Chen YC; Teng W; Hsieh YC; Chen WT; Jeng WJ; Huang CH; Lin CC; Chen YC; Lin SM; Lin CY; Sheen IS
J Formos Med Assoc; 2019 Aug; 118(8):1239-1246. PubMed ID: 30581103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
